Tag Archives: daiichi sankyo

Featured Stories

Pradaxa Associated with more Complications than Warfarin, According to Early Study Findings

Early results from the largest study to date to compare Pradaxa and warfarin indicate that in a real-world setting, Pradaxa causes more complications than decades-old warfarin. The preliminary study results were announced last week, during the 2012 Thrombosis and Hemostasis Summit of North America.

Read More

Actos Bladder Cancer Lawsuit Filed by West Virginia Resident

Actos (pioglitazone) continues to be named in lawsuits alleging long-term use of the type 2 diabetes drug caused patients to develop bladder cancer. Just last week, the national law firm of Parker Waichman LLP filed suit against Takeda Pharmaceuticals on behalf of a West Virginia man who developed bladder cancer ...

Read More

Older Patients Face Heart Attack Risk Following Surgery

Older Hip Implant, Knee Replacement Patients Face Heart Attack Risk Following Surgery

An emerging report reveals that older hip implant and knee replacement patients face increased heart attack risks following surgery. The risk for acute myocardial infarction (AMI) was seen in the first two weeks after these surgical procedures.

Read More

Three Injured, Long Island Railroad Train Hits Car on Tracks

Three Injured When Long Island Railroad Train Hits Car on Tracks

3 people, injured on Wednesday at 1:20 p.m. when a LIRR train hit a livery cab on the tracks west of Wyandanch station. The train engineer, who suffered a shoulder injury.

Read More

Toxic Nano-Particles from Failing Metal-on-Metal Hip Replacements May Pose Long-Term Health Risks

According to a new study, failing metal-on-metal hip implants generate toxic nano-particles that release Cobalt 2+ ions, which not only cause inflammation in surrounding tissue, but have the potential to cause long-term damage to the genetic material of cells. According to a report published by Medicalxpress.com, this “genotoxicity” could ...

Read More

Actos, Avandia May Up Risk for Diabetic Macular Edema

A newly published study is raising concerns that patients who take Actos or Avandia may face an increased risk of developing diabetic macular edema, an eye disorder that can result in vision loss. The study, published in the Archives of Internal Medicine, found that type 2 diabetics who use thiazolidinediones, ...

Read More

Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent

Yet another study is confirming the association between the diabetes drug, Actos, and bladder cancer. This latest research, published today in the Canadian Medical Association Journal, found that taking Actos raised the risk of bladder cancer among diabetics by about one-fifth.

Read More

Cancer Groups Issue Statement for Regulation of E-cigarettes

Cancer Groups Issue Statement Calling for Research and Regulation of E-cigarettes

The American Society of Clinical Oncology & the American Association for Cancer Research are calling on the government to regulate e-cigarettes.

Read More

Western Pennsylvania Familes File Suit Over Alleged Fracking Pollution

Three families in western Pennsylvania believe a leading hydraulic fracturing (fracking) company and two water testing labs are conspiring to produce false results that show natural gas drilling is not contaminating their private water wells.

Read More

Colorado Woman Sues American Medical Systems Over Transvaginal Mesh Injuries

Parker Waichman LLP, a national law firm, just filed a lawsuit on behalf of a Colorado woman allegedly injured by transvaginal mesh products manufactured by American Medical Systems, Inc. The suit was filed on May 21, 2012 in the U.S. District Court for the Northern District of California (Case No. ...

Read More

Oklahoma Woman Files Lawsuit over Benicar, Alleges Intestinal Problems

OK Woman Files Suit over Benicar, Alleges Intestinal Issues

A new lawsuit has been filed over Benicar, a medication used to treat patients with high blood pressure. An Oklahoma woman alleges that the drug, manufactured by Daiichi Sankyo, caused sprue-like enteropathy, intestinal problems causing chronic diarrhea. The lawsuit filed … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , |

Lawsuit Filed against Benicar Citing Psychological Damages

Lawsuit Filed against Benicar Citing Psychological Damages

A lawsuit has been filed by a man against Daiichi Sankyo claiming its blood pressure lowering medication Benicar was the reason for his psychological issues along with multiple physical injuries. The plaintiff’s Benicar lawsuit was filed within the multidistrict litigation … Continue reading

Posted in Pharmaceuticals | Tagged , , , , |

Mississippi Woman Files Benicar Lawsuit Alleging Drug Caused Colitis

MS Woman Files Benicar Lawsuit Alleging Drug Caused Colitis

A lawsuit filed recently on behalf of a Mississippi woman alleges that the blood-pressure drug Benicar HCT caused her colitis and other gastrointestinal complications. This lawsuit is part of a multidistrict litigation (MDL) in progress in federal court in New … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , , , , , , |

Lawsuit Alleges Benicar HCT Led to Colitis

Lawsuit Alleges Benicar HCT Led to Colitis

A new lawsuit has been filed over Benicar HCT (olmesartan medoxomil and hydrochlorothiazide), a hypertension medication manufactured by Daiichi-Sankyo and Forest Laboratories. The plaintiff is a Mississippi woman who began taking the drug in 2005. She developed colitis and other … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , , , , , , |

Lawsuit Alleges Benicar HCT Makers Failed to Warn about Risk of Intestinal Side Effects

Benicar HCT Makers Failed to Warn about Risk of Side Effects

Daiichi Sankyo and Forest Laboratories are facing a new lawsuit alleging the companies failed to warn about the risk of gastrointestinal injuries with Benicar HCT, a high blood pressure medication. The plaintiff began taking the drug in April 2006, and … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , , , , , , , , |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.